CLINICAL_TRIALS
trial_result
· 2023-09-08
Clinical Trial Update: Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients [Phase 3]
Summary
Phase 3 trial update on AI201901 for allergic rhinitis has completed, reporting efficacy and safety data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abdi Ibrahim Ilac San. ve Tic A.S. | Conditions: Allergic Rhinitis Due to Allergens | Phase 3 | Status: COMPLETED